Ferulic Acid-Loaded Lipid Nanostructures as Drug Delivery Systems for Alzheimer's Disease: Preparation, Characterization and Cytotoxicity Studies

被引:57
作者
Bondi, M. L. [1 ]
Montana, G. [2 ]
Craparo, E. F. [3 ]
Picone, P. [3 ]
Capuano, G. [3 ]
Di Carlo, M. [2 ]
Giammona, G. [3 ]
机构
[1] ISMN CNR, I-90146 Palermo, Italy
[2] IBIM CNR, I-90146 Palermo, Italy
[3] Univ Palermo, Dipartimento Chim & Tecnol Farmaceut, I-90123 Palermo, Italy
关键词
Solid lipid nanoparticles; ferulic acid; drug delivery; human neuroblastoma cells; Alzheimer's disease; FIBRILS IN-VITRO; AMYLOID FIBRILS; NANOPARTICLES; BRAIN;
D O I
10.2174/157341309787314656
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Ferulic acid (FA), a phenolic compound with a significant antioxidant activity in Alzheimer's disease, was entrapped into several solid lipid nanoparticles (SLN and NLC) by using the microemulsion technique. Stable SLN and NLC formulations having mean size ranging between 94-140 nm and high zeta potential were obtained. The SLN sample obtained by using as lipid matrix Compritol 888 ATO was chosen for further characterization because, among these particles, showed high Loading Capacity (LC%) and the best characteristics in terms of size, PDI, and drug release profile. Empty SLN showed no cytotoxicity on human neuroblastoma cells (LAN 5) at tested concentrations and the ability to penetrate into these cells. Moreover, cells treated with FA-loaded SLN showed a higher reduced ROS production than cells treated with free FA. These findings demonstrate that FA-loaded SLN possess a higher protective activity than free FA against oxidative stress induced in neurons and suggest that SLN are excellent carriers to transport FA into the cells.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 21 条
[1]   Active targeting of brain tumors using nanocarriers [J].
Beduneau, Arnaud ;
Saulnier, Patrick ;
Benoit, Jean-Pierre .
BIOMATERIALS, 2007, 28 (33) :4947-4967
[2]   PARTICLE-SIZE AND SIZE DISTRIBUTION OF POLY(BUTYL 2-CYANOACRYLATE) NANOPARTICLES .2. INFLUENCE OF STABILIZERS [J].
DOUGLAS, SJ ;
ILLUM, L ;
DAVIS, SS .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1985, 103 (01) :154-163
[3]   Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies [J].
Kanski, J ;
Aksenova, M ;
Stoyanova, A ;
Butterfield, DA .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2002, 13 (05) :273-281
[4]   Inhibitory effects of long-term administration of ferulic acid on microglial activation induced by intracerebroventricular injection of β-amyloid peptide (1-42) in mice [J].
Kim, HS ;
Cho, JY ;
Kim, DH ;
Yan, JJ ;
Lee, HK ;
Suh, HW ;
Song, DK .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (01) :120-121
[5]   Nanoparticulate systems for brain delivery of drugs [J].
Kreuter, J .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (01) :65-81
[6]  
Kreuter J., 1994, Encyclopedia of Pharmaceutical Technology, p165.190
[7]   A hybrid molecule that prohibits amyloid fibrils and alleviates neuronal toxicity induced by β-amyloid (1-42) [J].
Lee, KH ;
Shin, BH ;
Shin, KJ ;
Kim, DJ ;
Yu, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 328 (04) :816-823
[8]   In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles [J].
Lockman, PR ;
Koziara, J ;
Roder, KE ;
Paulson, J ;
Abbruscato, TJ ;
Mumper, RJ ;
Allen, DD .
PHARMACEUTICAL RESEARCH, 2003, 20 (05) :705-713
[9]   Solid lipid nanoparticles -: Production, characterization and applications [J].
Mehnert, W ;
Mäder, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (2-3) :165-196
[10]   Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease [J].
Morgan, D ;
Diamond, DM ;
Gottschall, PE ;
Ugen, KE ;
Dickey, C ;
Hardy, J ;
Duff, K ;
Jantzen, P ;
DiCarlo, G ;
Wilcock, D ;
Connor, K ;
Hatcher, J ;
Hope, C ;
Gordon, M ;
Arendash, GW .
NATURE, 2000, 408 (6815) :982-985